Massachusetts General Hospital Cancer Center

https://www.massgeneral.org/cancer-center

 

Massachusetts General Hospital Cancer Center
W

52 y/o Female With Localized PDAC: How Adequate Is Current Approach? Why Is Staging Important?

By Massachusetts General Hospital Cancer Center FEATURING Wells Messersmith, Theodore Hong
By Massachusetts General Hospital Cancer Center FEATURING Wells Messersmith, Theodore Hong
158 views
May 26, 2021
1 Comment
Login to view comments. Click here to Login
Grand Rounds
53:56
Massachusetts General Hospital Cancer Center

Oncologic Anthropology: Genetics of High-Risk/TNBC and African Ances…

Feat. L. Newman
56:23
Massachusetts General Hospital Cancer Center

Environmental Influences on Colorectal Cancer

Feat. J. Carethers
47:34
Massachusetts General Hospital Cancer Center

Confronting Inequity in Modern Therapy for Rare Melanomas

Feat. A. Shoushtari
47:29
Massachusetts General Hospital Cancer Center

Personalizing Care for Older Adults With Cancer

Feat. H. Klepin
50:19
Massachusetts General Hospital Cancer Center

Engineering CAR T-Cells: Combatting Tumor Resistance and Relapse

Feat. R. Brentjens
46:25
Massachusetts General Hospital Cancer Center

Advancing Therapies for Children and Adults With Rare Solid Tumors o…

Feat. B. Widemann
49:26
Massachusetts General Hospital Cancer Center

Turning on Apoptotic Switch in Leukemia: BCL-2 and Beyond

Feat. M. Konopleva
12:33
Massachusetts General Hospital Cancer Center

Endocrine Therapy in EBC: Latest Trial Data on Genomic Testing

Feat. N. Davidson
10:26
Massachusetts General Hospital Cancer Center

Radiation Therapy and Localized PDAC: NACRT vs. NAT, Radiation &…

Feat. W. Messersmith, T. Hong
18:49
Massachusetts General Hospital Cancer Center

RT & laPAC: Application in Unresectable Disease, Dose Escalation…

Feat. W. Messersmith, T. Hong
36:51
Massachusetts General Hospital Cancer Center

The Future of Cancer Screening: Non-Standard Screens, Death Rates &a…

Feat. S. Raoof
09:54
Massachusetts General Hospital Cancer Center

Augmenting Response to Endocrine Therapy in BC: The Role of Combinat…

Feat. N. Davidson
15:35
Massachusetts General Hospital Cancer Center

ESR1 Mutations and Other Mutational Signatures in HR+/HER2- MBC: Rev…

Feat. N. Davidson
12:39
Massachusetts General Hospital Cancer Center

Key Adjuvant Studies for Resected Pancreatic Adenocarcinoma: What Da…

Feat. W. Messersmith, T. Hong
12:09
Massachusetts General Hospital Cancer Center

The Role of CDK4/6i in Endocrine Therapy of HR+/HER2- MBC: 1/2L Trea…

Feat. N. Davidson
31:20
Massachusetts General Hospital Cancer Center

Understanding Responses to Cancer Therapy: Lessons Learned From Tran…

Feat. J. Wargo
12:43
Massachusetts General Hospital Cancer Center

What Is the Role of Diet in Response to Cancer Treatment?

Feat. J. Wargo
36:18
Massachusetts General Hospital Cancer Center

Molecular Profiling of Gliomas: Therapeutic Utility of Prognostic &a…

Feat. A. Chakravarti
22:43
Massachusetts General Hospital Cancer Center

The Use of IO in SCLC: Navigating Established IO Mono & Combinat…

Feat. T. Owonikoko
Massachusetts General Hospital Cancer Center

Enhancing the Benefit of IO in SCLC: Considering Emerging Predictive…

Feat. T. Owonikoko
15:48
Massachusetts General Hospital Cancer Center

52 y/o Female With Localized PDAC: How Adequate Is Current Approach?…

Feat. W. Messersmith, T. Hong
48:13
Massachusetts General Hospital Cancer Center

Late Recurrences in ER+ BC: Does Adjuvant ET Decrease the Risk of Re…

Feat. D. Hayes